Associate Cardiologist-in-Chief for Academic Affairs, Department of Cardiology, Boston Children’s Hospital; Commonwealth Professor of Pediatrics, Harvard Medical School
Associate Professor of Pediatrics, Division of Pediatric Cardiology, the University of Utah and Primary Children’s Hospital
About the Webinar
Multisystem inflammatory syndrome in children (MIS-C) is a rare complication of COVID-19 that is typically seen 2–6 weeks after a SARS-CoV-2 infection or exposure. Children and adolescents with MIS-C can be very sick and have a fever with significant inflammation that can affect several organ systems, including the heart and cardiovascular, gastrointestinal, mucocutaneous, hematologic, and neurologic systems. The Long-terM OUtcomes after the Multisystem Inflammatory Syndrome in Children (MUSIC) study, funded by the National Heart, Lung, and Blood Institute (NHLBI) and Primary Health Network (PHN), aims to characterize the acute and long-term cardiac and non-cardiac sequelae in MIS-C associated with COVID-19. The objectives of this webinar are to review the manifestations and current best treatments for MIS-C, the latest advances from the MUSIC study, and the epidemiology and manifestations of COVID-19 vaccine myocarditis.
About Jane W. Newburger
Dr. Jane W. Newburger’s major research interests include clinical outcomes and neurodevelopment in congenital heart disease, Kawasaki disease, and MIS-C. She is currently the principal investigator for the NHLBI and PHN-supported MUSIC study and is the cardiology lead for Centers for Disease Control and Prevention's Overcoming COVID-19 study. She also leads multicenter studies on long-term medical and neurodevelopmental outcomes in hypoplastic left heart syndrome, the impact of technical performance of cardiac surgeons, and the relationship of genetic factors to outcomes in children with heart disease. Dr. Newburger has authored more than 500 manuscripts, chapters, and reviews. She has received numerous awards including the American College of Cardiology’s Distinguished Scientist Award (Clinical), the American Heart Association’s Clinical Research Prize, the American Academy of Pediatrics’ Founders Award, and election to the National Academy of Medicine. She has served on the Board of Trustees of the American College of Cardiology and in leadership roles in a broad array of national organizations and journal editorial boards. In addition to her research, Dr. Newburger maintains a busy clinical practice comprised of patients with congenital and acquired heart disease.
About Dongngan Truong
Dr. Dongngan Truong is an Associate Professor of Pediatrics in the Division of Pediatric Cardiology at the University of Utah. She is the Medical Director of the Kawasaki Disease and MIS-C Clinic at the University of Utah. She co-leads the NHLBI and PHN-supported MUSIC study with Dr. Newburger.